Avanir Shareholders Can't Halt Proxy Vote

Law360, Los Angeles (February 12, 2014, 9:36 PM ET) -- A California federal judge on Wednesday allowed Avanir Pharmaceuticals Inc.'s shareholder vote on issues like executive pay to proceed despite the objections of a putative class of investors claiming that its proxy notice was misleading, ruling all the information required for an informed vote was in the notice. 

U.S. District Judge Cormac J. Carney denied the plaintiffs' motion for a preliminary injunction to stop the vote, which included a proposal to issue 17 million shares to be used for equity-based compensation. Avanir had claimed it was...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers


Case Information

Case Title

Robert Masters v. Avanir Pharmaceuticals Inc. et al

Case Number



California Central

Nature of Suit



Cormac J. Carney

Law360 Coverage

Date Filed

January 13, 2014


Law Firms Mentioned

Companies Mentioned

Government Agencies Mentioned

Related Articles